Incidence and clinical features of HHV-7 detection in lower respiratory tract in patients with severe pneumonia: a multicenter, retrospective study
Authors' conclusion
HHV-7 was detected in the lungs of 6.24% of patients with severe pneumonia.
Study context
- Population
- Patients with severe pneumonia requiring invasive mechanical ventilation who underwent metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid, 12 centres, January 2019 to March 2023
- Participants
- 721 patients · 12 centres
- Exposure
- HHV-7 positive vs HHV-7 negative in lower respiratory tract
- HHV-7 positiven = 45
- Outcome
- Incidence of HHV-7 detection in lower respiratory tract
Methodological detailsmulticentre, propensity-score matched
- Multicentre
- Propensity-score matched
Main finding
As reported in the abstract
HHV-7 detection in lower respiratory tract
HHV-7 positive
6.24%
45
Observational data: associations, not effects.
Further findings
Cytomegalovirus co-detection
P = 0.001
Epstein-Barr virus co-detection
P = 0.008
28-day mortality (propensity-matched) · propensity score matching
P = 0.395
| Outcome | HR (95% CI) | P value | |
|---|---|---|---|
| 28-day mortality (multivariate Cox regression) · adjusted for gender, age, SOFA score | 1.783 (0.936–3.400) | P = 0.079 | |
| 0.20.5125Hazard ratio (log scale) |
| Outcome | HHV-7 positive | HHV-7 negative | P value |
|---|---|---|---|
| Age | 59.2 | 64.4 | P = 0.032 |
- 28-day mortality (propensity-matched): matched for gender, age, SOFA at ICU admission, days from ICU admission to mNGS
Original publication
Incidence and clinical features of HHV-7 detection in lower respiratory tract in patients with severe pneumonia: a multicenter, retrospective study. Crit Care. Published 23 June 2023. doi:10. 1186/ s13054-023-04530-6
Composed by AI from the published abstract and checked against it. How Briefs are made →